Skip to main content

Advertisement

Log in

Readmission and Risk Factors for Readmission Following Esophagectomy for Esophageal Cancer

  • 2014 SSAT Plenary Presentation
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Introduction

Readmission after esophagectomy for esophageal cancer has not been systematically evaluated.

Study Objective

The objectives of this study were to determine national 30-day readmission rates after esophagectomy for esophageal cancer and evaluate risk factors associated with readmission.

Methods

Retrospective review of the 2011–2012 National Surgical Quality Improvement Program dataset was performed to identify patients who underwent elective esophagectomy for esophageal cancer.

Results

One thousand sixty-eight patients satisfied study criteria. One hundred and thirty-five patients were admitted within 30 days resulting in a readmission rate of 12.6 %. Patients with a history of pulmonary disease were 3.9 times more likely to be readmitted. Patients who developed postoperative wound-related complications were 9 times more likely to be readmitted than patients who did not develop wound-related complications. Increasing length of hospital stay was associated with a marginal but significant decrease in risk of readmission.

Conclusions

National 30-day readmission rate after esophagectomy for esophageal cancer is around 12.6 %. Risk factors associated with 30-day readmission include history of pulmonary disease, postoperative wound-related complications, and length of hospital stay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schneider EB, Hyder O, Brooke BS, Efron J, Cameron JL, Edil BH, Schulick RD, Choti MA, Wolfgang CL, Pawlik TM. Patient Readmission and Mortality after Colorectal Surgery for Colon Cancer: Impact of Length of Stay Relative to Other Clinical Factors. J Am Coll Surg 2012; 214:390–399.

    Article  PubMed  Google Scholar 

  2. Hechenbleikner EM, Makary MA, Samarov DV, Bennett JL, Gearhart SL, Efron JE, Wick EC. Hospital Readmission by Method of Data Collection. J Am Coll Surg 2013; 216:1150e1158.

    Article  Google Scholar 

  3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.

    Article  PubMed  Google Scholar 

  4. Kubo A, Corley D. Marked Regional Variation in Adenocarcinomas of the Esophagus and the Gastric Cardia in the United States. Cancer 2002; 95:2096–102.

    Article  PubMed  Google Scholar 

  5. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001; 92: 549– 555.

    Article  CAS  PubMed  Google Scholar 

  6. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia [see comments]. JAMA. 1991; 265: 1287–1289.

    Article  CAS  PubMed  Google Scholar 

  7. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998; 83: 2049 –2053.

    Article  CAS  PubMed  Google Scholar 

  8. Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA. 2013 Aug 14; 310(6): 627-36.

  9. Thomas A. D’Amico. Outcomes After Surgery for Esophageal Cancer. Gastrointest Cancer Res 1:188–196.

  10. Orringer MB, Marshall B, Iannettoni MD. Transhiatal Esophagectomy: Clinical Experience and Refinements. Ann Surg. 1999 September; 230(3): 392.

  11. Bailey SH, Bull DA, Harpole DH, Rentz JJ, Neumayer LA, Pappas TN, Daley J, Henderson WG, Krasnicka B, Khuri SF. Outcomes After Esophagectomy: A Ten-Year Prospective Cohort. Ann Thorac Surg 2003;75:217–22.

    Article  PubMed  Google Scholar 

  12. Kassin MT, Owen RM, Perez SD, Leeds I, Cox JC, Schnier K, Sadiraj V, Sweeney JF. Risk Factors for 30-Day Hospital Readmission among General Surgery Patients. J Am Coll Surg 2012; 215: 322–330.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Fuchshuber PR, Greif W, Tidwell CR, Klemm MS, Frydel C, Wali A, Rosas E, Clopp. The Power of the National Surgical Quality Improvement Program— Achieving A Zero Pneumonia Rate in General Surgery Patients. The Permanente Journal/ Winter 2012/ Volume 16 No. 1.

  14. ACS NSQIP PUF. http://site.acsnsqip.org/wp-content/uploads/2012/03/ACS-NSQIP-Participant-User-Data-File-User-Guide_06.pdf. Accessed May 2014.

  15. Gupta PK; Gupta H, Sundaram A, Kaushik M, Fang X, Miller WJ, Esterbrooks DJ, Hunter CJ, Pipinos II, Johanning JM, Lynch TG, Forse RA, Mohiuddin SM, Mooss AN. Development and Validation of a Risk Calculator for Prediction of Cardiac Risk After Surgery. Circulation. 2011; 124: 381-387.

    Article  PubMed  Google Scholar 

  16. Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves. Perioperative Outcomes and Decreases Recurrent Ischemic Events. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Circulation. 2004;109: 1497-1502

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sumeet K. Mittal.

Additional information

Discussant

Dr. Sharon M. Weber (Madison, WI): I congratulate the authors on a well presented study and very nicely written MS.

Using NSQIP to evaluate readmission introduces a number of biases—the largest of which is the difference in the definition of the 30d window--for the Medicare Hospital Readmission Reduction Program this is defined as 30d after discharge. Because NSQIP only collects readmission data over a shorter time period, inclusive of 30d following surgery, readmission rates are not comparable. This is likely part of the reason your 12 % readmission rate was lower than expected compared to other series of patients undergoing complex cancer surgery, in which the rate is around 20 %. In addition, the NSQIP time point of 30d following surgery creates issues with immortal person-time bias—the patient can only be readmitted after they have been discharged, so patients who have died are excluded. How did you handle the statistical analysis to account for person-time bias?

In addition, the time at risk for readmission is shorter for those with a longer LOS. Thus your analysis of LOS and its impact on readmission is problematic and I would caution you to not overextend your conclusions, as many other studies have shown longer LOS is associated with increased risk of readmission, due to its strong association with postoperative complications.

Many other studies have clearly shown that, for surgical patients, complications are the main driver of readmissions. It is helpful to understand the relationship of post-discharge complications, since this allows one to focus on those that are potentially actionable in order to concentrate efforts to decrease the readmission rate. Did you evaluate the time to readmission following discharge, to understand the drivers of readmission in the early period post-discharge? This might help focus readmission reduction interventions on the drivers of early post-discharge readmission. Finally, it is clearly a worthwhile endeavor to assess the risk factors for readmission, but ultimately the goal is to decrease unnecessary readmissions. What interventions is your group pursuing as a result of this research?

Closing Discussant

Dr. Sundaram: Thank you Dr. Weber for your insightful questions. The NSQIP does collect readmission data from the date of admission. The readmission rate in our study is probably an underestimate of the true readmission rate, as even though NSQIP tries to capture readmissions at both the index hospital and other hospitals, some readmissions will be missed. One of the objectives of this study was to analyze risk factors for readmission. It is logical that complications drive readmissions. Thus identification of complications associated with readmission would allow for modification of risk factors associated with these complications, thus impacting readmission. In our study we analyzed the incidence of 30 day and post discharge complications. It was evident that patients who were readmitted had a higher incidence of wound related complications and venous thromboembolic events. Thus prevention of these complications could potentially reduce the readmission rate. However, this is a preliminary study. Future studies should focus on prevention strategies and how these impact readmission. The study has made us cognizant of the fact that a vast majority of our esophagectomy patients develop complications after discharge. We have instituted several measures to combat wound related complications. All our esophagectomy patients receive 72 hrs. of perioperative antibiotics. They are placed on a tight control insulin drip to prevent fluctuations in their glucose levels in the immediate post-operative period. We are looking at how best we can optimize our post discharge surveillance, such that patients who develop complications are identified early so that these complications can be treated without adding further to the morbidity associated with the procedure.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sundaram, A., Srinivasan, A., Baker, S. et al. Readmission and Risk Factors for Readmission Following Esophagectomy for Esophageal Cancer. J Gastrointest Surg 19, 581–586 (2015). https://doi.org/10.1007/s11605-015-2756-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-015-2756-9

Keywords

Navigation